Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus alfentanil before electroconvulsive therapy for agitation
IRCT2014103119769N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and alfentanil in agitation (2 arms), sponsored by Arak University of Medical Sciences. Started Aug 2014; status: completed.
02
Drugs
dexmedetomidinealfentanil
03
Conditions
agitation
Beyond the preview
Go deeper on IRCT2014103119769N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014103119769N1.